<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02010814</url>
  </required_header>
  <id_info>
    <org_study_id>BIO</org_study_id>
    <secondary_id>PCOS Biobank</secondary_id>
    <nct_id>NCT02010814</nct_id>
  </id_info>
  <brief_title>Characterization of a Prospective Cohort of Women With PCOS</brief_title>
  <official_title>Metabolic and Endocrinological Characterization of a Prospective Cohort of Women With PCOS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Polycystic ovary syndrome (PCOS) is a common endocrine disorder in premenopausal women. PCOS
      is characterized by increase levels of testosterone, unwanted hair growth, adiposity,
      irregular menstrual cycle, and infertility. PCOS is associated with diabetes mellitus and
      cardiovascular diseases. Women with PCOS are reported to have increased levels of stress
      hormones, which may be associated with decreased quality of life. Increased testosterone
      levels in women may decrease the risk of osteoporosis. The aim of the present study is to
      measure levels of stress hormones in urine and describe quality of life using questionnaires.
      In addition we aim to characterize body composition and bone architecture using DXA and
      ExtremeCT.

      As part of the project, a Biobank with fasting blood samples from participants is
      established.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2012</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>bone mass density (BMD)</measure>
    <time_frame>baseline</time_frame>
    <description>BMD measured by DXA scans and ExtremeCT scans.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stress hormones</measure>
    <time_frame>Baseline</time_frame>
    <description>Measurement of cortisol and steroid metabolites in 24 hour urine samples</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>PCOS</arm_group_label>
    <description>Women fulfilling at least two of the three Rotterdam criteria for PCOS, including
Irregular menstrual cycle
Clinical/biochemical hyperandrogenemia
Polycystic ovaries</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and urine samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women with PCOS, diagnosed by the Rotterdam criteria which include at least two of the
        following:

          -  irregular mestrual cycle

          -  polycystic ovaries

          -  biochemical/clinical hyperandrogenemia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PCOS

        Exclusion Criteria:

          -  pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dorte Glintborg, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Endocrinology, Odense University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marianne Andersen, DMSci</last_name>
    <phone>0045 65412502</phone>
    <email>marianne.andersen@rsyd.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Endocrinology, Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorte Glintborg, MD PhD</last_name>
      <phone>0045 65412502</phone>
      <email>dorte.glintborg@rsyd.dk</email>
    </contact>
    <investigator>
      <last_name>Marianne Andersen, DMSci</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2013</study_first_submitted>
  <study_first_submitted_qc>December 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2013</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Marianne Andersen</investigator_full_name>
    <investigator_title>DMSci</investigator_title>
  </responsible_party>
  <keyword>PCOS</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Body Composition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

